FDA NDC Directory · JSON-LD · Markdown

TAZAROTENE

NDC 45802-436 · HUMAN PRESCRIPTION DRUG · GEL

Generic nametazarotene
Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA213079
Dosage form / routeGEL · TOPICAL
Active ingredientsTAZAROTENE (.5 mg/g)
Marketing started20230605
Package count2

External sources

Source: openFDA. Public-domain (CC0).